US Stock MarketDetailed Quotes

GDTC CytoMed Therapeutics

Watchlist
  • 2.560
  • +0.060+2.40%
Close Feb 14 16:00 ET
  • 2.560
  • 0.0000.00%
Post 20:01 ET
29.54MMarket Cap-12.93P/E (TTM)

CytoMed Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-145.48%-3.43M
18.36%-1.4M
-101.66%-1.71M
-849.44K
Net income from continuing operations
-32.04%-4.13M
-52.53%-3.13M
-6.01%-2.05M
---1.94M
Operating gains losses
2,075.11%252.51K
-95.75%11.61K
31,046.55%273.26K
---883
Depreciation and amortization
-2.98%381.15K
19.09%392.87K
12.77%329.88K
--292.53K
Other non cash items
-290.48%-234.44K
7.65%123.08K
8.35%114.33K
--105.52K
Change In working capital
-4.53%104.92K
129.76%109.9K
-419.44%-369.25K
--115.59K
-Change in receivables
96.38%-5.26K
66.48%-145.17K
-167.27%-433.12K
---162.05K
-Change in payables and accrued expense
-56.81%110.18K
299.37%255.07K
-77.00%63.87K
--277.64K
Cash from discontinued investing activities
Operating cash flow
-145.48%-3.43M
18.36%-1.4M
-101.66%-1.71M
---849.44K
Investing cash flow
Cash flow from continuing investing activities
-497.75%-2.83M
42.54%-473.31K
-60.54%-823.67K
-513.05K
Net PPE purchase and sale
87.68%-58.3K
18.73%-473.31K
-137.96%-582.35K
---244.73K
Net intangibles purchase and sale
----
----
----
---20.43K
Net business purchase and sale
--0
--0
---241.31K
--0
Net investment purchase and sale
---2.77M
--0
--0
---247.9K
Cash from discontinued investing activities
Investing cash flow
-497.75%-2.83M
42.54%-473.31K
-60.54%-823.67K
---513.05K
Financing cash flow
Cash flow from continuing financing activities
1,027.25%10.92M
-76.79%968.72K
121.57%4.17M
1.88M
Net issuance payments of debt
-164.39%-340.43K
-144.23%-128.76K
-80.45%291.09K
--1.49M
Net common stock issuance
824.80%11.31M
-38.87%1.22M
300.00%2M
--500K
Cash dividends paid
--0
--0
--0
--0
Net other financing activities
----
----
--2M
----
Cash from discontinued financing activities
Financing cash flow
1,027.25%10.92M
-76.79%968.72K
121.57%4.17M
--1.88M
Net cash flow
Beginning cash position
-37.13%1.58M
183.84%2.51M
138.66%885.27K
--370.94K
Current changes in cash
615.82%4.66M
-155.17%-903K
214.14%1.64M
--521.03K
Effect of exchange rate changes
55.37%-13.41K
-224.92%-30.05K
-38.15%-9.25K
---6.7K
End cash Position
294.01%6.22M
-37.13%1.58M
183.84%2.51M
--885.27K
Free cash flow
-86.47%-3.49M
18.43%-1.87M
-105.93%-2.3M
---1.11M
Currency Unit
SGD
SGD
SGD
SGD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
--
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -145.48%-3.43M18.36%-1.4M-101.66%-1.71M-849.44K
Net income from continuing operations -32.04%-4.13M-52.53%-3.13M-6.01%-2.05M---1.94M
Operating gains losses 2,075.11%252.51K-95.75%11.61K31,046.55%273.26K---883
Depreciation and amortization -2.98%381.15K19.09%392.87K12.77%329.88K--292.53K
Other non cash items -290.48%-234.44K7.65%123.08K8.35%114.33K--105.52K
Change In working capital -4.53%104.92K129.76%109.9K-419.44%-369.25K--115.59K
-Change in receivables 96.38%-5.26K66.48%-145.17K-167.27%-433.12K---162.05K
-Change in payables and accrued expense -56.81%110.18K299.37%255.07K-77.00%63.87K--277.64K
Cash from discontinued investing activities
Operating cash flow -145.48%-3.43M18.36%-1.4M-101.66%-1.71M---849.44K
Investing cash flow
Cash flow from continuing investing activities -497.75%-2.83M42.54%-473.31K-60.54%-823.67K-513.05K
Net PPE purchase and sale 87.68%-58.3K18.73%-473.31K-137.96%-582.35K---244.73K
Net intangibles purchase and sale ---------------20.43K
Net business purchase and sale --0--0---241.31K--0
Net investment purchase and sale ---2.77M--0--0---247.9K
Cash from discontinued investing activities
Investing cash flow -497.75%-2.83M42.54%-473.31K-60.54%-823.67K---513.05K
Financing cash flow
Cash flow from continuing financing activities 1,027.25%10.92M-76.79%968.72K121.57%4.17M1.88M
Net issuance payments of debt -164.39%-340.43K-144.23%-128.76K-80.45%291.09K--1.49M
Net common stock issuance 824.80%11.31M-38.87%1.22M300.00%2M--500K
Cash dividends paid --0--0--0--0
Net other financing activities ----------2M----
Cash from discontinued financing activities
Financing cash flow 1,027.25%10.92M-76.79%968.72K121.57%4.17M--1.88M
Net cash flow
Beginning cash position -37.13%1.58M183.84%2.51M138.66%885.27K--370.94K
Current changes in cash 615.82%4.66M-155.17%-903K214.14%1.64M--521.03K
Effect of exchange rate changes 55.37%-13.41K-224.92%-30.05K-38.15%-9.25K---6.7K
End cash Position 294.01%6.22M-37.13%1.58M183.84%2.51M--885.27K
Free cash flow -86.47%-3.49M18.43%-1.87M-105.93%-2.3M---1.11M
Currency Unit SGDSGDSGDSGD
Audit Opinions Unqualified OpinionUnqualified Opinion----
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.34%
Micron Technology
MU
+4.04%
NVIDIA
NVDA
+2.63%
Cisco
CSCO
+1.61%
Netflix
NFLX
+1.43%

Unlock the Full List